v3.25.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated (Deficit) Surplus
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2023   1,286,570,294      
Balance, beginning of the period at Dec. 31, 2023 $ 9,066 $ 9,201 $ 251 $ 4 $ (390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   351,486      
Exercise of stock options 3 $ 6 (3)    
Stock-based compensation 105   105    
Vesting of restricted share units (in shares)   1,206,213      
Vesting of restricted share units 0 $ 76 (76)    
Net income (loss) and comprehensive income (loss) for the year (281)     (8) (273)
Common shares outstanding, ending balance (in shares) at Mar. 31, 2024   1,288,127,993      
Balance, end of the period at Mar. 31, 2024 8,893 $ 9,283 277 (4) (663)
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2023   1,286,570,294      
Balance, beginning of the period at Dec. 31, 2023 9,066 $ 9,201 251 4 (390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) and comprehensive income (loss) for the year (111)        
Common shares outstanding, ending balance (in shares) at Jun. 30, 2024   1,289,799,290      
Balance, end of the period at Jun. 30, 2024 9,172 $ 9,368 301 (5) (492)
Common shares outstanding, beginning balance (in shares) at Mar. 31, 2024   1,288,127,993      
Balance, beginning of the period at Mar. 31, 2024 8,893 $ 9,283 277 (4) (663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   451,202      
Exercise of stock options 3 $ 4 (1)    
Stock-based compensation 106   106    
Vesting of restricted share units (in shares)   1,220,095      
Vesting of restricted share units 0 $ 81 (81)    
Net income (loss) and comprehensive income (loss) for the year 170     (1) 171
Common shares outstanding, ending balance (in shares) at Jun. 30, 2024   1,289,799,290      
Balance, end of the period at Jun. 30, 2024 9,172 $ 9,368 301 (5) (492)
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2024   1,294,580,140      
Balance, beginning of the period at Dec. 31, 2024 11,558 $ 9,634 305 (10) 1,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,190,811      
Exercise of stock options 59 $ 87 (28)    
Stock-based compensation 114   114    
Vesting of restricted share units (in shares)   1,055,597      
Vesting of restricted share units (2) $ 86 (88)    
Issuance of shares related to business acquisition (in shares)   252,257      
Issuance of shares related to business acquisition 0 $ 24 (24)    
Net income (loss) and comprehensive income (loss) for the year (678)     4 (682)
Common shares outstanding, ending balance (in shares) at Mar. 31, 2025   1,297,078,805      
Balance, end of the period at Mar. 31, 2025 11,051 $ 9,831 279 (6) 947
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2024   1,294,580,140      
Balance, beginning of the period at Dec. 31, 2024 $ 11,558 $ 9,634 305 (10) 1,629
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 2,323,439        
Net income (loss) and comprehensive income (loss) for the year $ 239        
Common shares outstanding, ending balance (in shares) at Jun. 30, 2025   1,299,368,184      
Balance, end of the period at Jun. 30, 2025 12,124 $ 9,985 281 5 1,853
Common shares outstanding, beginning balance (in shares) at Mar. 31, 2025   1,297,078,805      
Balance, beginning of the period at Mar. 31, 2025 11,051 $ 9,831 279 (6) 947
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares)   1,132,628      
Exercise of stock options 44 $ 68 (24)    
Stock-based compensation 113   113    
Vesting of restricted share units (in shares)   1,156,751      
Vesting of restricted share units (1) $ 86 (87)    
Net income (loss) and comprehensive income (loss) for the year 917     11 906
Common shares outstanding, ending balance (in shares) at Jun. 30, 2025   1,299,368,184      
Balance, end of the period at Jun. 30, 2025 $ 12,124 $ 9,985 $ 281 $ 5 $ 1,853